COVID-19, Flu A or Flu B share the same symptoms, making it hard to distinguish among the three virus infections.Differential diagnosis for optimal target treatment requires combined testing to identify the specific virus(es) infected.
The Needs
Accurate differential diagnosis is crucial to guide appropriate antiviral therapy.
Although sharing same symptoms, COVID-19, Flu A and Flu B infections need different antiviral treatment. Influenza can be treated with neuraminidase inhibitors and severe COVID-19 with remdesivir/sotrovimab.
Positive result in one virus does not mean that you are free from others. Co-infections increase risks of severe disease, hospitalization, death due to synergistic effects.
Accurate diagnosis via multiplex testing is crucial to guide appropriate antiviral therapy, especially with potential co-infections during peak respiratory virus season.
Our Solutions
Macro & Micro-Test's SARS-CoV-2, Influenza A&B Antigen Combined Detection, differentiates Flu A, Flu B and COVID-19 along with potential multi-infections during the respiratory disease season;
Rapid testing of multiple respiratory infections, including SARS-CoV-2, Flu A, and Flu B by one sample;
Fully integrated test strip with only one application area and single sample needed to differentiate among Covid-19, Flu A and Flu B;
4 steps only for rapid results in only 15-20 min, enabling faster clinical decision making.
Multiple sample types: Nasopharyngeal, Oropharyngeal or Nasal;
Storage Temperature: 4 -30°C;
Shelf Life: 24 Months.
Multiple scenarios as hospitals, clinics, community health centers, pharmacies, etc.
|
SARS-CoV-2 |
Flu A |
Flu B |
|
|
Sensitivity |
94.36% |
94.92% |
93.79% |
|
Specificity |
99.81% |
99.81% |
100.00% |
|
Accuracy |
98.31% |
98.59% |
98.73% |
Post time: Jan-18-2024